Pharmaceutical company AstraZeneca isn’t running out of rakes to step on anytime soon. Less than a day after the company announced promising preliminary results from the U.S. trial of its covid-19 vaccine jointly developed with Oxford University, an independent panel of scientists monitoring the study issued a harsh rebuttal. The…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.